LIANBIO-ADR (LIAN)
US53000N1081 - ADR
ChartMill assigns a Buy % Consensus number of 43% to LIAN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.98. This target is 1147.02% above the current price.
LIAN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about LIAN.
In the previous month the buy percentage consensus was at a similar level.
LIAN was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-03 | B of A Securities | Downgrade | Buy -> Underperform |
| 2023-12-22 | Jefferies | Downgrade | Buy -> Hold |
| 2023-10-25 | Raymond James | Maintains | Outperform -> Outperform |
| 2022-10-14 | Raymond James | Maintains | Outperform |
| 2021-11-26 | Goldman Sachs | Initiate | Neutral |
| 2021-11-26 | Jefferies | Initiate | Buy |
| 2021-11-24 | Raymond James | Initiate | Outperform |